ALTIMMUNE, INC. Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ALTIMMUNE, INC. payments for repurchase of warrants for the quarter ending 2019-12-31 was $0.00.
- ALTIMMUNE, INC. payments for repurchase of warrants for the quarter ending 2018-12-31 was $0.00.
- ALTIMMUNE, INC. payments for repurchase of warrants for the quarter ending 2018-09-30 was $0.00.
- ALTIMMUNE, INC. payments for repurchase of warrants for fiscal 2019 was $25.00K, a 97.73% decline from fiscal 2018.
- ALTIMMUNE, INC. payments for repurchase of warrants for fiscal 2018 was $1.10M.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $25.00K 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.10M 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |